Skip to main content

Table 1 Demographic characteristics and preoperative clinical features of the two groups of patients

From: A comparison of the da Vinci Xi vs. da Vinci Si surgical systems for radical prostatectomy

Variables

Xi (n = 82)

Si (n = 93)

p value

Age, median (range), year

67.2 (50, 82)

68.1 (51, 85)

0.415

BMI, median (range), kg/m2

22.6 (18.6, 29)

22.1 (19, 29)

0.075

Diabetes mellitus, n (%)

8 (9.8)

11 (11.8)

0.809

Hypertension, n (%)

29 (35.4)

42 (42.5)

0.218

History of abdominal or pelvic surgery, n (%)

15 (18.3)

20 (21.5)

0.706

ASA score < 3, n (%)

72 (87.8)

81 (87.1)

1.000

ASA score ≥ 3, n (%)

10 (12.2)

12 (12.9)

1.000

Preoperative PSA, mean (SD), ng/ml

59.6 (85.6)

47.6 (82)

0.347

Prostate volume, mean (SD), ml

36.4 (18.8)

35.4 (18.5)

0.734

Biopsy Gleason score, n (%)

  ≤ 6

9 (11)

12 (12.9)

0.817

  = 7

28 (34.1)

26 (28)

0.415

  ≥ 8

45 (54.9)

54 (58.1)

0.760

Clinical T stage, n (%)

 cT2a

15 (18.3)

21 (22.6)

0.575

 cT2b

52 (63.4)

45 (48.4)

0.490

 cT2c

10 (12.2)

17 (17.2)

0.399

 cT3a

5 (6.1)

11 (11.8)

0.293

D’Amico risk classification, n (%)

 Low

1 (1.2)

1 (1.1)

1.000

 Intermediate

21 (25.6)

17 (18.3)

0.273

 High

60 (73.2)

75 (80.6)

0.281

  1. SD standard deviation, BMI body mass index, ASA American Society of Anesthesiologists, PSA prostate-specific antigen